Results by Type
News Results 1-10 of 52
Sponsored Links
Kidney Cancer Diagnosis?
Learn About Chemotherapy and How it is Used to Treat Kidney Cancer.
Kidney Cancer Diagnosis?
Learn How Neulasta Can Help Support Your Body's Natural Defenses.
Cancer Research UK expresses 'deep concern' on kidney cancer drug decision
News | www.news-medical.net | Aug 8, 2008
Cancer Research UK - the largest publicly funded research charity in the UK - wants to see the way NICE review the value of drugs altered for rare diseases, such as this type of kidney cancer, where clinical benefit is proven but evidence is limited. Cancer Research UK - the largest publicly funded
U.K. National Health Service decides that 4 new drugs with some activity against kidney cancer are not cost-effective.
News | news.bbc.co.uk | Aug 7, 2008
Patients with advanced kidney cancer in England and Wales are to be denied four treatments on the NHS under new plans.
Watchdog says "no" to four kidney cancer drugs
News | uk.news.yahoo.com | Aug 7, 2008
Kidney cancer patients should not be treated with four expensive new medicines on the National Health Service, the country's health cost-effectiveness watchdog said on Thursday.
http://uk.news.yahoo.com/rtrs/20080807/thl-uk-britain-cancer-drugs-8004a53.html
Draft NICE guidance could deny kidney cancer patients life-extending treatment
Press Release | www.pharmiweb.com | Aug 7, 2008
News and press releases from the pharmaceutical industry. Comprehensive news coverage for the pharmaceutical sector from PharmiWeb.com
http://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=4272
New drug prolongs survival of advanced kidney cancer
News | uk.reuters.com | Jul 23, 2008
NEW YORK (Reuters Health) - Treatment with everolimus can significantly improve the progression-free survival of patients with advanced kidney cancer that has not responded to other treatments, according
http://uk.reuters.com/article/healthNews/idUKCOL36097820080723?feedType=RSS&feedName=healthNews
Stanford researchers find molecule that kills kidney cancer cells, STF-62247.
News | www.eurekalert.org | Jul 8, 2008
Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ. But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells.
http://www.eurekalert.org/pub_releases/2008-07/sumc-srf070208.php
Stanford University School of Medicine Researchers Find Molecule that Kills Kidney Cancer Cells
News | www.biospace.com | Jul 7, 2008
STANFORD, Calif.--(BUSINESS WIRE)--Kidney cancer patients generally have one option for beating their disease: surgery to remove the organ. But that could change, thanks to a new molecule found by Stanford University School of Medicine researchers that kills kidney cancer cells. Ideally, the
http://www.biospace.com/news_story.aspx?StoryID=102519&full=1
Vaccine Therapy Disappoints for Kidney Cancer
News | www.medpagetoday.com | Jul 3, 2008
HOUSTON -- The tumor-derived vaccine vitespen (Oncophage) does not prevent kidney cancer recurrence or improve survival despite promising early results, researchers said.
http://www.medpagetoday.com/HematologyOncology/OtherCancers/tb/10015
Novartis Steals The Show
News | www.forbes.com | Jun 2, 2008
Novartis emerges as the surprise winner at this year's meeting of the American Society of Clinical Oncology.
RAD001 More Than Doubles Time Without Tumour Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer (PR Newswire)
Press Release | biz.yahoo.com | May 27, 2008
RAD001 More Than Doubles Time Without Tumour Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer. - FRIMLEY, England, May 27 /PRNewswire/ --
http://biz.yahoo.com/prnews/080527/3667408en_public.html?.v=1
Sponsored Links
Researching Kidney Cancer
Learn about a minimally invasive approach to kidney surgery
How To Beat Kidney Cancer
Free 100 page report details ways to effectively reverse cancer.
Or copy the embed script code below and paste it on your website:
Embed code:
>
